Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for INVELTYS™ (KPI-121 1%)

by Carolyn Helms | Oct 25, 2017 | Portfolio News

Molecular Templates Announces Dosing of First Patient in Phase 1 Expansion Study of MT-3724 in Diffuse Large B-Cell Lymphoma (DLBCL)

by Carolyn Helms | Oct 24, 2017 | Portfolio News

Rapid Micro Biosystems Awarded Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Final Implementation of Rapid Sterility Test for Vaccines

by Carolyn Helms | Oct 23, 2017 | Portfolio News

Sema4 Announces Collaboration With California Cryobank To Improve And Expand Genetic Screening For Sperm Donors

by Carolyn Helms | Oct 17, 2017 | Portfolio News

Aimmune Therapeutics Announces Clinical Collaboration to Study AR101 with Regeneron and Sanofi’s Dupilumab for Peanut Allergy

by Carolyn Helms | Oct 16, 2017 | Portfolio News

« Older Entries
Next Entries »

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • X
  • RSS
footer-logo

LP Login

© 2026 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer